2MORROW INC

Kirkland, WA · Founded 2012 · Digital health · Private

Digital therapeutic mobile application delivering Acceptance and Commitment Therapy (ACT) protocols for chronic pain management

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · 2morrow.co

Sector: Digital health
Headquarters: Kirkland, WA
Founded: 2012
Latest Form D: $3.3M, Apr 2021
Total capital: $7.7M

Federal grants: $3.6M; 4 awards · 2021–2023; Rank in peer group#16 of 35
Private capital raised: $4.1M; 5 Form D · last Apr 2021; 66 months since last filing
Federal contracts: $30K; 1 award · Defense; Rank in Digital health#40 of 818
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Sep 2023Federal grantHealth and Human S · Phase II · HEAL - Development and implementation of a provider prescribed, behavioral digital therapeutic designed to support, educate, screen and remotely monitor patients with chronic pain$499K
Sep 2022Federal grantHealth and Human S · Phase II · HEAL -Development and implementation of a provider prescribed, behavioral digital therapeutic designed to support, educate, screen and remotely monitor patients with chronic pain$1.7M
Sep 2022Federal grantHealth and Human S · Phase II · HEAL - Development and implementation of a provider prescribed, behavioral digital therapeutic designed to support, educate, screen and remotely monitor patients with chronic pain$1.2M
Apr 2021Federal grantHealth and Human S · Phase II · HEAL - Development and implementation of a provider prescribed, behavioral digital therapeutic designed to support, educate, screen and remotely monitor patients with chronic pain$252K
Apr 2021Private capital raisedForm D · SEC · 5th filing$3.3M
Oct 2018Private capital raisedForm D · SEC · 4th filing$200K
Apr 2018Private capital raisedForm D · SEC · 3rd filing$150K
Apr 2016Private capital raisedForm D · SEC · 2nd filing$325K
Mar 2015Private capital raisedForm D · SEC · 1st filing$50K

Show 1 earlier federal award

Jun 2016Federal contractDefense · Igf::ot::igf Support For Smartquit Study$30K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 35 peers

Line = median

Digital health · Software

Federal grants#16 · top 46%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Jo MastersonResearcherExecutive OfficerLinked by $3.6M in grants as PI
Brandon MastersonExecutive Officer, DirectorNamed in SEC Form D filings
Eric LarsenDirectorNamed in SEC Form D filings
John KosterDirectorNamed in SEC Form D filings
Kim HansenExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

HYPNALGESICS, LLCSimilar federal contract value in Digital health · $50K in contracts
NEUROGENECES, INC.Similar federal contract value in Digital health · $50K in contracts
Soliddd Corp.Similar federal contract value in Digital health · $50K in contracts
AvoMD, Inc.Similar federal contract value in Digital health · $20K in contracts
Cognixion CorpSimilar federal contract value in Digital health · $15K in contracts
Limbix Health, Inc.Similar federal contract value in Digital health · $14K in contracts

Regulatory activity · Digital health

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.